Lannfelt L

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (13)

Title : Altered amyloid-beta structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion - Pagnon_2024_Acta.Neuropathol.Commun_12_22
Author(s) : Pagnon de la Vega M , Syvanen S , Giedraitis V , Hooley M , Konstantinidis E , Meier SR , Rokka J , Eriksson J , Aguilar X , Spires-Jones TL , Lannfelt L , Nilsson LNG , Erlandsson A , Hultqvist G , Ingelsson M , Sehlin D
Ref : Acta Neuropathologica Commun , 12 :22 , 2024
Abstract : Pagnon_2024_Acta.Neuropathol.Commun_12_22
ESTHER : Pagnon_2024_Acta.Neuropathol.Commun_12_22
PubMedSearch : Pagnon_2024_Acta.Neuropathol.Commun_12_22
PubMedID: 38317196

Title : [Alzheimer's disease - the most common cause of dementia] - Bogdanovic_2020_Lakartidningen_117_
Author(s) : Bogdanovic N , Hansson O , Zetterberg H , Basun H , Ingelsson M , Lannfelt L , Blennow K
Ref : Lakartidningen , 117 : , 2020
Abstract : Bogdanovic_2020_Lakartidningen_117_
ESTHER : Bogdanovic_2020_Lakartidningen_117_
PubMedSearch : Bogdanovic_2020_Lakartidningen_117_
PubMedID: 32154904

Title : mRNA GPR162 changes are associated with decreased food intake in rat, and its human genetic variants with impairments in glucose homeostasis in two Swedish cohorts - Caruso_2016_Gene_581_139
Author(s) : Caruso V , Sreedharan S , Carlini VP , Jacobsson JA , Haitina T , Hammer J , Stephansson O , Crona F , Sommer WH , Riserus U , Lannfelt L , Marcus C , Heilig M , de Barioglio SR , Fredriksson R , Schioth HB
Ref : Gene , 581 :139 , 2016
Abstract : Caruso_2016_Gene_581_139
ESTHER : Caruso_2016_Gene_581_139
PubMedSearch : Caruso_2016_Gene_581_139
PubMedID: 26827797

Title : Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease - Hoglund_2012_J.Alzheimers.Dis_32_939
Author(s) : Hoglund K , Bogstedt A , Fabre S , Aziz A , Annas P , Basun H , Minthon L , Lannfelt L , Blennow K , Andreasen N
Ref : J Alzheimers Dis , 32 :939 , 2012
Abstract : Hoglund_2012_J.Alzheimers.Dis_32_939
ESTHER : Hoglund_2012_J.Alzheimers.Dis_32_939
PubMedSearch : Hoglund_2012_J.Alzheimers.Dis_32_939
PubMedID: 22936008

Title : The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wiig_2010_Acta.Neurol.Scand_121_186
Author(s) : Wiig EH , Annas P , Basun H , Andreasen N , Lannfelt L , Zetterberg H , Blennow K , Minthon L
Ref : Acta Neurologica Scandinavica , 121 :186 , 2010
Abstract : Wiig_2010_Acta.Neurol.Scand_121_186
ESTHER : Wiig_2010_Acta.Neurol.Scand_121_186
PubMedSearch : Wiig_2010_Acta.Neurol.Scand_121_186
PubMedID: 19785641

Title : Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wesnes_2010_Acta.Neurol.Scand_122_270
Author(s) : Wesnes K , Edgar C , Andreasen N , Annas P , Basun H , Lannfelt L , Zetterberg H , Blennow K , Minthon L
Ref : Acta Neurologica Scandinavica , 122 :270 , 2010
Abstract : Wesnes_2010_Acta.Neurol.Scand_122_270
ESTHER : Wesnes_2010_Acta.Neurol.Scand_122_270
PubMedSearch : Wesnes_2010_Acta.Neurol.Scand_122_270
PubMedID: 20047570

Title : Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study - Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
Author(s) : Degerman Gunnarsson M , Lindau M , Wall A , Blennow K , Darreh-Shori T , Basu S , Nordberg A , Larsson A , Lannfelt L , Basun H , Kilander L
Ref : Dementia & Geriatric Cognitive Disorders , 29 :204 , 2010
Abstract : Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
ESTHER : Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
PubMedSearch : Degerman_2010_Dement.Geriatr.Cogn.Disord_29_204
PubMedID: 20332638

Title : Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial - Lannfelt_2008_Lancet.Neurol_7_779
Author(s) : Lannfelt L , Blennow K , Zetterberg H , Batsman S , Ames D , Harrison J , Masters CL , Targum S , Bush AI , Murdoch R , Wilson J , Ritchie CW
Ref : Lancet Neurol , 7 :779 , 2008
Abstract : Lannfelt_2008_Lancet.Neurol_7_779
ESTHER : Lannfelt_2008_Lancet.Neurol_7_779
PubMedSearch : Lannfelt_2008_Lancet.Neurol_7_779
PubMedID: 18672400

Title : Longitudinal stability of CSF biomarkers in Alzheimer's disease - Blennow_2007_Neurosci.Lett_419_18
Author(s) : Blennow K , Zetterberg H , Minthon L , Lannfelt L , Strid S , Annas P , Basun H , Andreasen N
Ref : Neuroscience Letters , 419 :18 , 2007
Abstract : Blennow_2007_Neurosci.Lett_419_18
ESTHER : Blennow_2007_Neurosci.Lett_419_18
PubMedSearch : Blennow_2007_Neurosci.Lett_419_18
PubMedID: 17482358

Title : Plasma Levels of Abeta42 and Abeta40 in Alzheimer Patients during Treatment with the Acetylcholinesterase Inhibitor Tacrine - Basun_2002_Dement.Geriatr.Cogn.Disord_14_156
Author(s) : Basun H , Nilsberth C , Eckman C , Lannfelt L , Younkin S
Ref : Dementia & Geriatric Cognitive Disorders , 14 :156 , 2002
Abstract : Basun_2002_Dement.Geriatr.Cogn.Disord_14_156
ESTHER : Basun_2002_Dement.Geriatr.Cogn.Disord_14_156
PubMedSearch : Basun_2002_Dement.Geriatr.Cogn.Disord_14_156
PubMedID: 12218259

Title : Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes - Svensson_1997_Neurosci.Lett_232_37
Author(s) : Svensson AL , Warpman U , Hellstrom-Lindahl E , Bogdanovic N , Lannfelt L , Nordberg A
Ref : Neuroscience Letters , 232 :37 , 1997
Abstract : Svensson_1997_Neurosci.Lett_232_37
ESTHER : Svensson_1997_Neurosci.Lett_232_37
PubMedSearch : Svensson_1997_Neurosci.Lett_232_37
PubMedID: 9292886

Title : [Alzheimer disease and related conditions. Increased knowledge. New preparations are on the way] -
Author(s) : Basun H , Lannfelt L
Ref : Lakartidningen , 93 :4617 , 1996
PubMedID: 8999254

Title : Characterization of muscarinic acetylcholine receptors in cultured adult skin fibroblasts: effects of the Swedish Alzheimer's disease APP 670\/671 mutation on binding levels - Vestling_1995_J.Neural.Transm.Park.Dis.Dement.Sect_10_1
Author(s) : Vestling M , Cowburn RF , Venizelos N , Lannfelt L , Winblad B , Adem A
Ref : J Neural Transm Park Dis Dement Sect , 10 :1 , 1995
Abstract : Vestling_1995_J.Neural.Transm.Park.Dis.Dement.Sect_10_1
ESTHER : Vestling_1995_J.Neural.Transm.Park.Dis.Dement.Sect_10_1
PubMedSearch : Vestling_1995_J.Neural.Transm.Park.Dis.Dement.Sect_10_1
PubMedID: 8619905